Total Payments
$13,372
2024 Payments
$188.34
Companies
34
Transactions
132
Medicare Patients
7,243
Medicare Billing
$1.1M
Payment Breakdown by Category
Consulting$8,709 (65.1%)
Food & Beverage$2,179 (16.3%)
Other$1,566 (11.7%)
Travel$892.73 (6.7%)
Gifts$25.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $8,709 | 2 | 65.1% |
| Food and Beverage | $2,179 | 111 | 16.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,551 | 15 | 11.6% |
| Travel and Lodging | $892.73 | 2 | 6.7% |
| Gift | $25.00 | 1 | 0.2% |
| Entertainment | $14.96 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| HOLOGIC INC | $9,858 | 9 | $0 (2022) |
| Amgen Inc. | $1,664 | 21 | $0 (2019) |
| Smith+Nephew, Inc. | $473.47 | 39 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $209.80 | 8 | $0 (2024) |
| Carl Zeiss Meditec, Inc. | $163.92 | 4 | $0 (2021) |
| Focal Therapeutics, Inc. | $102.61 | 2 | $0 (2019) |
| MAYNE PHARMA INC. | $85.68 | 4 | $0 (2022) |
| Endomagnetics Ltd | $81.66 | 2 | $0 (2021) |
| PUMA BIOTECHNOLOGY, INC. | $78.18 | 5 | $0 (2021) |
| Tempus AI, Inc | $56.36 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $188.34 | 10 | Tempus AI, Inc ($56.36) |
| 2023 | $171.57 | 6 | Myriad Genetic Laboratories, Inc. ($81.75) |
| 2022 | $7,251 | 38 | HOLOGIC INC ($6,823) |
| 2021 | $385.74 | 17 | Smith+Nephew, Inc. ($102.14) |
| 2020 | $109.86 | 6 | Endomagnetics Ltd ($25.00) |
| 2019 | $555.87 | 12 | Amgen Inc. ($327.20) |
| 2018 | $3,290 | 23 | HOLOGIC INC ($3,035) |
| 2017 | $1,420 | 20 | Amgen Inc. ($1,256) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Pharma Products | ||||||
| 12/04/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $13.59 | General |
| 10/31/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 09/19/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Pharma Products | ||||||
| 08/22/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $17.75 | General |
| 07/11/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $25.02 | General |
| 05/09/2024 | Bard Peripheral Vascular, Inc. | PowerPort M.R.I. Implantable Port (Device) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Vascular/Oncology | ||||||
| 04/10/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: ONCOLOGY | ||||||
| 02/28/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Pharma Products | ||||||
| 11/08/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $81.75 | General |
| Category: ONCOLOGY | ||||||
| 10/26/2023 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Pain Management | ||||||
| 09/20/2023 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 07/06/2023 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Pharma Products | ||||||
| 05/10/2023 | Smith+Nephew, Inc. | STRAVIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Extra Cellular Matrix | ||||||
| 02/22/2023 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Pharma Products | ||||||
| 12/19/2022 | Smith+Nephew, Inc. | STRAVIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Extra Cellular Matrix | ||||||
| 12/01/2022 | Becton, Dickinson and Company | — | Food and Beverage | In-kind items and services | $17.45 | General |
| 11/18/2022 | Smith+Nephew, Inc. | STRAVIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $7.52 | General |
| Category: Extra Cellular Matrix | ||||||
| 09/28/2022 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Pharma Products | ||||||
| 09/20/2022 | Smith+Nephew, Inc. | STRAVIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: Extra Cellular Matrix | ||||||
| 09/14/2022 | Myriad Genetic Laboratories, Inc. | myRisk (Device) | Food and Beverage | Cash or cash equivalent | $18.13 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 08/18/2022 | HOLOGIC INC | — | Food and Beverage | In-kind items and services | $28.69 | General |
| 07/28/2022 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Pharma Products | ||||||
| 07/08/2022 | Smith+Nephew, Inc. | STRAVIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: Extra Cellular Matrix | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,546 | 1,657 | $1.3M | $221,476 |
| 2022 | 27 | 1,865 | 2,010 | $1.7M | $302,406 |
| 2021 | 27 | 2,000 | 2,141 | $1.8M | $324,068 |
| 2020 | 25 | 1,832 | 2,010 | $1.5M | $281,634 |
Total Patients
7,243
Total Services
7,818
Medicare Billing
$1.1M
Procedure Codes
108
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 3 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 41 | 42 | $4,452 | $1,508 | 33.9% |
| 11601 | Removal of cancer skin growth of body, arms, or legs, 0.6-1.0 cm | Facility | 2022 | 12 | 13 | $8,502 | $744.03 | 8.8% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 12 | 12 | $6,372 | $731.45 | 11.5% |
| 15271 | Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | Facility | 2022 | 12 | 12 | $9,528 | $412.10 | 4.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 108 | 112 | $2,800 | $327.23 | 11.7% |
| 77001 | Fluoroscopic guidance for insertion or removal of central vein access device | Facility | 2022 | 23 | 23 | $10,327 | $318.34 | 3.1% |
| 19301 | Partial removal of breast | Facility | 2021 | 100 | 102 | $172,628 | $38,937 | 22.6% |
| 19083 | Biopsy of breast accessed through the skin with ultrasound guidance, first lesion | Office | 2021 | 87 | 89 | $146,494 | $34,703 | 23.7% |
| 19318 | Breast reduction | Facility | 2021 | 42 | 42 | $283,038 | $33,401 | 11.8% |
| 14301 | Tissue transfer repair of wound (30.1 to 60.0 sq centimeters) | Facility | 2021 | 65 | 65 | $148,590 | $26,090 | 17.6% |
| 19303 | Total removal of breast | Facility | 2021 | 31 | 31 | $91,147 | $25,913 | 28.4% |
| 38525 | Biopsy or removal of lymph nodes of under the arm, open procedure | Facility | 2021 | 131 | 131 | $250,559 | $23,920 | 9.5% |
| 76642 | Ultrasound of one breast, limited | Office | 2021 | 239 | 293 | $65,157 | $17,532 | 26.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 216 | 279 | $49,941 | $17,096 | 34.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 180 | 180 | $47,700 | $14,249 | 29.9% |
| 38900 | Lymph node imaging during surgery | Facility | 2021 | 131 | 131 | $48,015 | $13,752 | 28.6% |
| 19125 | Removal of breast growth, open procedure | Facility | 2021 | 37 | 38 | $62,548 | $12,325 | 19.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 106 | 106 | $43,354 | $12,268 | 28.3% |
| 14302 | Tissue transfer repair of wound (30.0 sq centimeters) | Facility | 2021 | 57 | 57 | $33,288 | $9,386 | 28.2% |
| 36561 | Insertion of central venous catheter and implanted device for infusion beneath the skin, patient 5 years or older | Facility | 2021 | 28 | 29 | $110,316 | $6,565 | 6.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 77 | $20,405 | $6,518 | 31.9% |
| 19294 | Preparation of tumor cavity and placement of radiation therapy applicator into breast for radiation therapy concurrent with partial breast removal | Facility | 2021 | 51 | 51 | $21,828 | $6,412 | 29.4% |
| 93702 | Lymphedema assessment for extracellular fluid analysis | Office | 2021 | 48 | 48 | $14,736 | $4,818 | 32.7% |
| 19081 | Biopsy of breast accessed through the skin with stereotactic guidance, first lesion | Facility | 2021 | 39 | 39 | $18,681 | $4,686 | 25.1% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2021 | 49 | 49 | $15,729 | $3,762 | 23.9% |
About Dr. Phillip Ley, M.D
Dr. Phillip Ley, M.D is a Surgical Oncology healthcare provider based in Flowood, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790890499.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Phillip Ley, M.D has received a total of $13,372 in payments from pharmaceutical and medical device companies, with $188.34 received in 2024. These payments were reported across 132 transactions from 34 companies. The most common payment nature is "Consulting Fee" ($8,709).
As a Medicare-enrolled provider, Ley has provided services to 7,243 Medicare beneficiaries, totaling 7,818 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgical Oncology
- Location Flowood, MS
- Active Since 08/20/2006
- Last Updated 08/19/2020
- Taxonomy Code 2086X0206X
- Entity Type Individual
- NPI Number 1790890499
Products in Payments
- VIERA (Device) $2,040
- IMLYGIC (Biological) $1,551
- COLLAGENASE SANTYL (Drug) $194.34
- IORT (Device) $163.92
- MYRISK (Device) $119.90
- myRisk (Device) $89.90
- GRAFIX PL (Medical Supply) $78.13
- STRAVIX (Medical Supply) $77.07
- STRAVIX PL (Medical Supply) $69.05
- Ultrasound (Device) $63.92
- BioZorb (Device) $63.41
- Magseed (Device) $56.66
- INNOVAMATRIX AC (Device) $53.01
- Nerlynx (Drug) $52.55
- SPY-PHI SYSTEM (Device) $49.45
- Prolia (Biological) $45.06
- Savi SCOUT (Device) $39.27
- Biozorb (Device) $39.20
- Viera (Device) $38.37
- Herceptin (Biological) $36.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.